Discover latest product news and media coverage about Ultromics.
Show all
EchoGo is the first AI-powered tool to automate echocardiography analysis as a cloud service, to streamline doctor’s workflows and help save them time
Ultromics and Mayo Clinic Partner to Use AI to Improve Diagnosis of Heart Failure. Read more about innovative AI solutions here.
Read more about the AI Solution by Ultromics that Predicts Heart Disease To Be Implemented In NHS Hospitals in our latest news article.
Ultromics receive $10m funding to accelerate innovation and growth for EchoGo. Read more here.
Learn more about how tools like EchoGo can provide off-cart analysis and diagnosis that can enhance workflow efficiencies and reduce exposure to COVID.
Ultromics, with it's innovative AI solutions, collaborates with Mayo Clinic to optimize the impact of AI tools on care pathways. Read more about it here.
Mayo Clinic has collaborated with Ultromics to rapidly assess patients diagnosed with COVID-19. Read more about the collaboration here.
Ultromics CE marked its automated coronary artery disease prediction system, EchoGo Pro, allowing it to be used commercially across the UK and the EU.
Ultromics has achieved the ISO 27001 certification. Read more about Ultromics and our innovative AI solutions here.
Ultromics has received FDA clearance for its AI-powered decision support system, EchoGo Core. Read more about it here.
Researchers at an Oxford hospital have developed an artificial intelligence (AI) that can diagnose scans for heart disease and lung cancer.
Ultromics is now a founding partner of AI centre of excellence. Read more about how AI can make an impact in patient outcomes.
Sign-up to hear about the latest news.
Sign up to newsletter
cases processed
